Cargando…
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Over the past decades, immunotherapy has demonstrated a prominent clinical efficacy in a wide variety of human tumors. For many years, apoptosis has been considered a non-immunogenic or tolerogenic process whereas necrosis or necroptosis has long been acknowledged to play a key role in inflammation...
Autores principales: | Serrano-del Valle, Alfonso, Anel, Alberto, Naval, Javier, Marzo, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476910/ https://www.ncbi.nlm.nih.gov/pubmed/31041312 http://dx.doi.org/10.3389/fcell.2019.00050 |
Ejemplares similares
-
Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019) -
Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019) -
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022) -
Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022) -
The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells
por: Wang, Mengdong, et al.
Publicado: (2023)